Get in before earnings

2021年2月11日

Posted previously on this

Following up with a new post as it is nearing catalysts and technicals have suggested that it has broke out of a long consolidation period

I personally think this is due for a major run where the March earnings call should bring a lot of positivity to this stock. I'll be expecting encouraging first quarter sales of Olinvyk, their FDA approved drug that could potentially replace morphine and address opioid shortage. TRVN is also expected to report on their top-line data for another drug TRV027 this quarter.
genengnews.com/covid-19-candidates/trevena-trv027/

4 months price target: $7
Long term price target: TBD

2021年2月23日

註釋

Dropped a significant amount since my post but overall market is seeing red too. Will be holding this through their earnings

2021年3月29日

交易進行

Been averaging down on this